Schizophrenia: Clinical Trials

23 trials for Schizophrenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 unknown. 23 Phase 2, 7 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 223Unknown 23
Phase 17Unknown 7
Phase 34Unknown 4

Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
HS-10380, Placebo - Schizophrenia
Phase 1 / Phase 2UnknownJiangsu Hansoh Pharmaceutical Co., Ltd.1122023-07-302023-07-28
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
Pyridoxine, Cobalamin, Placebo Oral Tablet - Schizophrenia, Drug Induced Movement Disorder, Unspecified
Phase 2 / Phase 3UnknownNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara452019-09-032019-12-18
Pentoxifylline Add-on Therapy for Schizophrenia
Oxopurin - Schizophrenia
Phase 1 / Phase 2UnknownMazra Mental Health Center902019-04-202021-10-11
Add-on Methotrexate for the Treatment of Schizophrenia
Methotrexate, Placebo Arm - Schizophrenia
Phase 2UnknownSheba Medical Center1002017-12-152017-12-12
Siltuximab in Schizophrenia
Siltuximab, normal saline - Schizophrenia, Psychotic Disorders
Phase 1 / Phase 2UnknownBrian Miller302016-05-012023-07-21
rTMS Treatment for Positive and Negative Symptoms of Schizophrenia
rTMS - Schizophrenia
Phase 2 / Phase 3UnknownSt. Joseph's Healthcare Hamilton202016-02-012019-04-22
Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination
Direct Current Stimulation, Dextromethorphan - Schizophrenia
Phase 1 / Phase 2UnknownUniversity of Ottawa122015-04-012015-04-27
Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia
Tolcapone - Schizophrenia
Phase 2UnknownClinica Universidad de Navarra, Universidad de Navarra202014-09-222024-04-29
Famotidine in Schizophrenia
Famotidine, Placebo - Schizophrenia
Phase 2 / Phase 3UnknownJesper Ekelund1402014-03-012015-04-14
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
Risperidone, Olanzapine, Quetiapine - Schizophrenia
Phase 1 / Phase 2UnknownShanxi Medical University2002013-01-012016-01-08
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia
D-serine, placebo, Sensory Based remediation paradigm - Schizophrenia, Schizoaffective Disorder
Phase 2UnknownNathan Kline Institute for Psychiatric Research162012-03-012012-10-25
High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
D-serine - Schizophrenia
Phase 2UnknownHadassah Medical Organization542011-11-012011-10-25
Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia
repetitive Transcranial Magnetic Stimulation (Magstim rapid2 ), repetitive Transcranial Magnetic Stimulation (Magstim rapid2), repetitive Transcranial Magnetic Stimulation(Magstim rapid2) - Schizophrenia
Phase 2UnknownUniversity of Tehran302011-01-012015-09-01
Is MS14 Helpful in Schizophrenia?
MS14, Risperidone - Schizophrenia
Phase 2UnknownFarzan Institute502010-02-012010-03-09
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia
Suo Quan Wan, Wu Lin San, Placebo - Schizophrenia, Clozapine
Phase 2UnknownTaichung Veterans General Hospital452010-01-012010-01-14
Transcranial Magnetic Stimulation (TMS) in Schizophrenia
DEEP TMS H1 coil, Deep H1 coil TMS - Schizophrenia
Phase 2 / Phase 3UnknownBeerYaakov Mental Health Center202008-10-012010-03-03
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
MEM 3454, Placebo for MEM 3454 - Schizophrenia
Phase 2UnknownMemory Pharmaceuticals122008-08-012008-07-31
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Aripiprazole, Perphenazine - Schizophrenia, Cocaine Dependence
Phase 2UnknownPaul Saenger442008-08-012012-09-07
The Effect of Intranasal Administration of Oxytocin on Empathic Abilities.
Oxytocin (also: syntocinon, pitocin), Placebo - Schizophrenia
Phase 2UnknownShalvata Mental Health Center1002008-05-012009-02-05
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
modified cognitive behavioural therapy (mCBT) - Psychotic Disorders, Schizophrenia
Phase 2UnknownUniversity of Cologne422007-05-012009-02-20

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Psychotic Disorders (5)  ·  Cocaine-Related Disorders (1)  ·  Inflammation (1)  ·  Medication Adherence (1)  ·  Schizophrenia, Paranoid (1)  ·  Sialorrhea (1)

Broader conditions

Mental Disorders (23)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (23)  ·  Behavior (1)  ·  Chemically-Induced Disorders (1)  ·  Health Behavior (1)  ·  Mouth Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Patient Acceptance of Health Care (1)  ·  Patient Compliance (1)  ·  Salivary Gland Diseases (1)  ·  Stomatognathic Diseases (1)  ·  Substance-Related Disorders (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Aripiprazole (2)  ·  Risperidone (2)  ·  Dextromethorphan (1)  ·  Drug Evaluation (1)  ·  Famotidine (1)  ·  Methotrexate (1)  ·  Olanzapine (1)  ·  Oxytocin (1)  ·  Pentoxifylline (1)  ·  Perphenazine (1)  ·  Pyridoxine (1)  ·  Quetiapine Fumarate (1)  ·  Saline Solution (1)  ·  Tolcapone (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

Sheba Medical Center (2)  ·  BeerYaakov Mental Health Center (1)  ·  Brian Miller (1)  ·  Clinica Universidad de Navarra, Universidad de Navarra (1)  ·  Farzan Institute (1)  ·  Hadassah Medical Organization (1)  ·  Herzog Hospital (1)  ·  Jesper Ekelund (1)  ·  Jiangsu Hansoh Pharmaceutical Co., Ltd. (1)  ·  Lady Reading Hospital, Pakistan (1)  ·  Mazra Mental Health Center (1)  ·  Memory Pharmaceuticals (1)  ·  Nathan Kline Institute for Psychiatric Research (1)  ·  Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara (1)  ·  Paul Saenger (1)

Countries

Israel (6)  ·  United States (4)  ·  Canada (2)  ·  Iran (2)  ·  Brazil (1)  ·  China (1)  ·  Finland (1)  ·  Germany (1)  ·  Pakistan (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Amit Lotan, MD (1)  ·  Andreas Bechdolf, PD Dr. (1)  ·  Ann Olincy, MD, MPH (1)  ·  Bernard Lerer, MD (1)  ·  Danielle Impey, Ph.D. (cand.) (1)  ·  Gary Chaimowitz, MD, FRCPC (1)  ·  Jesper Ekelund, MD, PhD (1)  ·  Joshua T Kantrowitz, MD (1)  ·  Lia LO Sanders, MD, PhD (1)  ·  Mark Weiser, MD (1)  ·  Oded Rosenberg, M.D. (1)  ·  Patricio Molero, MD, PhD (1)  ·  Pesach Lichtenberg, M.D. (1)  ·  Saeed Farooq, MCPS,FCPS (1)  ·  Seyed Vahid Shariat (1)

Results publications

PMID 21303566, PMID 21565135, PMID 22559192, PMID 22795211